PROGNOSTIC VALUE OF CELL CYCLE PROTEINS p27 ^kip1 AND MIB-1, AND THE CELL ADHESION PROTEIN CD44s IN SURGICALLY TREATED PATIENTS WITH PROSTATE CANCER

This publication has 22 references indexed in Scilit:

• Prognostic significance of p27Kip1 expression in colorectal cancer: a clinico-pathological characterization
  The Journal of Pathology, 1999
• Association of p27Kipl Levels With Recurrence and Survival in Patients With Stage C Prostate Carcinoma
  JNCI Journal of the National Cancer Institute, 1998
• Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update
  Published by American Medical Association (AMA) ,1997
• Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas
  Nature Medicine, 1997
• Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancer
  Nature Medicine, 1997
• Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients
  Nature Medicine, 1997
• Evaluation of a Nomogram used to predict the pathologic stage of clinically localized prostate carcinoma
  Cancer, 1997
• Analysis of Risk Factors for Progression in Patients with Pathologically Confined Prostate Cancers After Radical Retropubic Prostatectomy
  Journal of Urology, 1996
• Prediction of Progression Following Radical Prostatectomy
  The American Journal of Surgical Pathology, 1996
• p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.
  Genes & Development, 1994